4/10
09:25 am
pacb
Rating for PACB
Medium
Report
Rating for PACB
3/25
10:25 am
pacb
Rating for PACB
Low
Report
Rating for PACB
3/25
10:25 am
pacb
Rating for PACB
Low
Report
Rating for PACB
2/18
11:21 am
pacb
Rating for PACB
Low
Report
Rating for PACB
2/18
11:21 am
pacb
Rating for PACB
Low
Report
Rating for PACB
2/18
11:21 am
pacb
Rating for PACB
Low
Report
Rating for PACB
2/18
09:19 am
pacb
Rating for PACB
Medium
Report
Rating for PACB
2/14
11:48 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $2.50 price target on the stock.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $2.50 price target on the stock.
2/14
11:48 am
pacb
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $2.50 price target on the stock.
Medium
Report
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $2.50 price target on the stock.
2/14
11:38 am
pacb
Rating for PACB
Medium
Report
Rating for PACB
1/23
11:11 am
pacb
Rating for PACB
Low
Report
Rating for PACB
1/23
11:11 am
pacb
Rating for PACB
Low
Report
Rating for PACB
1/23
11:11 am
pacb
Rating for PACB
Low
Report
Rating for PACB